These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7042069)

  • 21. On the presence of autoantibodies in the plasma of patients suffering from medullary carcinoma of the thyroid.
    Calmettes C
    Biomed Pharmacother; 1985; 39(4):195-8. PubMed ID: 3904856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum tissue polypeptide antigen (TPA) in thyroid cancer.
    Martino E; Bambini G; Aghini-Lombardi F; Motz E; Pacini F; Lari R; Baschieri L; Pinchera A
    J Endocrinol Invest; 1984 Jun; 7(3):249-52. PubMed ID: 6547969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of FoxA1 expression in thyroid tumors.
    Nonaka D
    Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretion of calcitonin and carcinoembryonic antigen in long-term organ culture of human medullary thyroid carcinoma: biochemical and immunocytochemical studies.
    Raue F; Boller G; Rix E; Schmidt-Gayk H; Ziegler R
    Klin Wochenschr; 1985 Mar; 63(5):205-10. PubMed ID: 3990162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C cell adenoma of the thyroid: a rare but distinct clinical entity.
    Kodama T; Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M; Hirayama A
    Surgery; 1988 Dec; 104(6):997-1003. PubMed ID: 3194851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF; Fritsche HA; Samaan NA
    J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid antibodies.
    Sobrinho-Simões M; Nesland JM; Johannessen JV
    Am J Surg Pathol; 1987 Oct; 11(10):821-4. PubMed ID: 3661825
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of serum carcinoembryonic antigen in preoperative diagnosis of cancer in patients with thyroid nodules.
    Madeddu G; Langer M; Dettori G; Costanza C
    Cancer; 1980 May; 45(10):2607-10. PubMed ID: 7378994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
    Papapetrou PD; Polymeris A
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical characteristics of carcinoembryonic antigen extracted from medullary carcinoma of the thyroid.
    Jullienne A; Calmettes C; Moukhtar MS; Milhaud G
    Oncodev Biol Med; 1980; 1(3):137-42. PubMed ID: 7279700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
    Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
    Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitonin-like polypeptides without apparent biological activity in a patient with recurrent medullary thyroid carcinoma.
    Nakajima K; Jinkawa I; Hirota T; Ikeda T; Tugawa M; Minami Y; Hanada M
    Intern Med; 1995 Sep; 34(9):896-900. PubMed ID: 8580565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
    Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers in C-cell cancer].
    Raue F; Schmidt-Gayk H; Ziegler R
    Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of carcinoembryonic antigen in medullary thyroid carcinoma by immunofluorescent techniques.
    Hamada S; Hamada S
    Br J Cancer; 1977 Nov; 36(5):572-6. PubMed ID: 337999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
    Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood plasma content of hormones and carcinoembryonic antigen in tumorous and nontumorous disease of the thyroid].
    Ivanov PK; Tkacheva GA
    Vopr Onkol; 1982; 28(4):29-34. PubMed ID: 7090265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.